{
  "simulation_id": "sim_20250502_195236",
  "config": {
    "use_team_leadership": false,
    "use_closed_loop_comm": false,
    "use_mutual_monitoring": false,
    "use_shared_mental_model": false,
    "use_team_orientation": false,
    "use_mutual_trust": true,
    "mutual_trust_factor": 0.2,
    "use_recruitment": false,
    "recruitment_method": "adaptive",
    "recruitment_pool": "general",
    "random_leader": false,
    "task": "Autoimmune Encephalitis Diagnosis"
  },
  "exchanges": [
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Critical Analyst",
      "message": "**Answer: B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating my initial analysis with the insights provided by my teammates, the consensus strongly supports **anti-LGI1 antibodies** as the most likely cause of this patient\u2019s presentation. The key findings include:\n\n1. **Clinical Presentation**: Subacute onset of memory deficits, confusion, and behavioral changes over 3 weeks is highly characteristic of limbic encephalitis, a syndrome commonly associated with anti-LGI1 antibodies.\n2. **MRI Findings**: Bilateral medial temporal lobe hyperintensities are a hallmark of anti-LGI1 encephalitis.\n3. **CSF Findings**: Mild lymphocytic pleocytosis aligns with the inflammatory process seen in anti-LGI1 encephalitis.\n4. **EEG Findings**: Focal slowing in the temporal regions is consistent with medial temporal lobe dysfunction, a key feature of limbic encephalitis caused by anti-LGI1 antibodies.\n5. **Differentiation from Other Options**:\n   - **Anti-NMDA receptor antibodies (A)**: Less likely due to the absence of hallmark features such as dyskinesias, autonomic instability, or prominent psychiatric symptoms. MRI findings are typically normal or nonspecific in anti-NMDA receptor encephalitis.\n   - **Anti-GABA-B receptor antibodies (C)**: Less likely due to the absence of seizures and the patient\u2019s younger age, as this condition is often paraneoplastic and occurs in older adults.\n   - **Anti-AMPA receptor antibodies (D)**: Less likely due to the rarity of this condition, its association with malignancies, and the less specific imaging and clinical findings compared to anti-LGI1 encephalitis.\n\nGiven the alignment across clinical, imaging, and laboratory findings, **anti-LGI1 antibodies (B)** are the most likely autoantibodies associated with this patient\u2019s presentation."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Domain Expert",
      "message": "**Answer: B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating my own analysis with the insights provided by teammates, the consensus strongly supports **anti-LGI1 antibodies** as the most likely cause of this patient\u2019s presentation. The clinical features (subacute onset of memory deficits, confusion, and behavioral changes), imaging findings (bilateral medial temporal lobe hyperintensities), CSF findings (mild lymphocytic pleocytosis), and EEG findings (focal slowing in the temporal regions) are all hallmark characteristics of **anti-LGI1 encephalitis**, a subtype of limbic encephalitis.\n\nKey supporting points include:\n1. The **MRI findings** of bilateral medial temporal lobe hyperintensities are highly specific for limbic encephalitis associated with anti-LGI1 antibodies.\n2. The **CSF analysis** showing mild lymphocytic pleocytosis aligns with the inflammatory nature of autoimmune encephalitis.\n3. The **EEG findings** of focal slowing in the temporal regions correlate with medial temporal lobe dysfunction, which is classic for anti-LGI1 encephalitis.\n4. The patient's **age and clinical presentation** fit well within the demographic and symptomatology of anti-LGI1 encephalitis, as opposed to other options like anti-GABA-B or anti-AMPA receptor antibodies, which are more commonly associated with malignancies and older age groups.\n\nWhile anti-NMDA receptor encephalitis is a common cause of autoimmune encephalitis, the absence of hallmark features such as psychiatric symptoms, dyskinesias, or autonomic instability makes it less likely in this case.\n\nThus, **anti-LGI1 antibodies (Option B)** are the most consistent with this patient's clinical, imaging, and laboratory findings."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Creative Strategist",
      "message": "**Answer: B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter reviewing the analyses from all team members and integrating their insights with my own expertise, the most likely autoantibody associated with this clinical presentation is **anti-LGI1 antibodies**. \n\nThe reasoning is as follows:\n1. **Clinical Features**: Subacute onset of memory deficits, confusion, and behavioral changes over 3 weeks is a hallmark of limbic encephalitis, which is strongly associated with anti-LGI1 antibodies.\n2. **Imaging**: Bilateral medial temporal lobe hyperintensities on MRI are classic for anti-LGI1 encephalitis.\n3. **CSF Findings**: Mild lymphocytic pleocytosis is consistent with an inflammatory or autoimmune process, as seen in anti-LGI1 encephalitis.\n4. **EEG Findings**: Focal slowing in the temporal regions aligns with medial temporal lobe dysfunction, further supporting the diagnosis.\n5. **Exclusion of Other Options**:\n   - Anti-NMDA receptor antibodies (Option A): More commonly associated with psychiatric symptoms, seizures, and dyskinesias, with less specific MRI findings.\n   - Anti-GABA-B receptor antibodies (Option C): Often linked to seizures and paraneoplastic syndromes, which are not present here.\n   - Anti-AMPA receptor antibodies (Option D): Rare and typically associated with malignancies, which are not indicated in this case.\n\nThe convergence of clinical, imaging, and laboratory findings makes **anti-LGI1 antibodies** the most plausible diagnosis. This consensus is supported by all team members' analyses, further affirming the choice."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Process Facilitator",
      "message": "**Single letter selection with rationale: B**\n\n### Final Answer:\nThe most likely autoantibody associated with this clinical presentation is **B. Anti-LGI1 antibodies**.\n\n### Integrated Rationale:\nAfter reviewing and synthesizing the analyses from all team members, the consensus strongly supports **anti-LGI1 antibodies** as the correct answer. This conclusion is based on the following key points:\n\n1. **Clinical Presentation**:\n   - Subacute onset of **memory deficits, confusion, and behavioral changes** over 3 weeks is highly suggestive of limbic encephalitis, a syndrome commonly associated with anti-LGI1 antibodies.\n   - While faciobrachial dystonic seizures (FBDS) are a hallmark of anti-LGI1 encephalitis, their absence does not exclude the diagnosis.\n\n2. **Imaging Findings**:\n   - **Bilateral medial temporal lobe hyperintensities** on MRI are a classic feature of anti-LGI1 encephalitis, strongly supporting this diagnosis.\n\n3. **Laboratory Findings**:\n   - **Mild lymphocytic pleocytosis** in the CSF is consistent with an inflammatory or autoimmune process.\n   - EEG findings of **focal slowing in the temporal regions** align with dysfunction in the medial temporal lobes.\n\n4. **Demographic Considerations**:\n   - Anti-LGI1 encephalitis is more common in middle-aged adults, matching the patient's age (32 years). While it is slightly less common in younger adults compared to older ones, it remains the most likely diagnosis in this case.\n\n5. **Comparison with Other Options**:\n   - **Anti-NMDA receptor antibodies (Option A)**: While anti-NMDA receptor encephalitis can present with psychiatric symptoms and memory deficits, the MRI findings of bilateral medial temporal lobe hyperintensities are not typical, making this less likely.\n   - **Anti-GABA-B receptor antibodies (Option C)**: This condition is more common in older adults and is frequently associated with malignancies (e.g., small-cell lung cancer). The absence of seizures and malignancy makes this less likely.\n   - **Anti-AMPA receptor antibodies (Option D)**: This condition is also associated with malignancies and is less common overall. The clinical presentation and imaging findings are less characteristic compared to anti-LGI1 encephalitis.\n\n### Conclusion:\nThe clinical, imaging, and laboratory findings are most consistent with **anti-LGI1 antibodies**, making **B** the correct answer."
    }
  ],
  "decision_results": {
    "majority_voting": {
      "method": "majority_voting",
      "winning_option": "B",
      "vote_counts": {
        "B": 3,
        "A": 1
      },
      "total_votes": 4,
      "confidence": 0.75
    },
    "weighted_voting": {
      "method": "weighted_voting",
      "winning_option": "B",
      "weighted_votes": {
        "B": 2.0999999999999996,
        "A": 0.7
      },
      "total_weight": 2.8,
      "confidence": 0.7499999999999999
    },
    "borda_count": {
      "method": "borda_count",
      "winning_option": "B",
      "borda_scores": {
        "A": 9,
        "B": 11,
        "C": 4,
        "D": 0
      },
      "total_possible_score": 24.0,
      "confidence": 0.4583333333333333
    }
  },
  "teamwork_metrics": {
    "mutual_trust": {
      "average_trust_level": 0.19591211182098645,
      "trust_network": {
        "Critical Analyst": {
          "Domain Expert": 0.15801407247175145,
          "Creative Strategist": 0.27920124513913325,
          "Process Facilitator": 0.1362525938924981
        },
        "Domain Expert": {
          "Critical Analyst": 0.1519145727348903,
          "Creative Strategist": 0.2687366197565729,
          "Process Facilitator": 0.10434425993159152
        },
        "Creative Strategist": {
          "Critical Analyst": 0.20288549700877206,
          "Domain Expert": 0.14347147396769325,
          "Process Facilitator": 0.10167780783559804
        },
        "Process Facilitator": {
          "Critical Analyst": 0.25673883847990475,
          "Domain Expert": 0.29796435031693236,
          "Creative Strategist": 0.2497440103164995
        }
      },
      "mistake_admission_rates": {},
      "feedback_acceptance_rates": {},
      "trust_environment": "low"
    }
  }
}